The Latest Breaking News from European Commission

From Saint-Tropez to Amalfi, the region’s most attractive tourist destinations are also its most vulnerable.

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Cameroon has emerged as one of several go-to countries for the widely criticized “flags of convenience” system, under which companies can -- for a fee -- register their ships in a foreign country even though there is no link between the vessel and the nation whose flag it flies

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Grace period will stop at end of 2022 with talks on a solution stalled

Romanian judges and prosecutors on Tuesday criticised proposed changes to judicial legislation they said would weaken the fight against graft in one of the European Union's most corrupt states.

Antisemitic incidents have shown a sharp rise in the United States. The Anti-Defamation League, a New York-based Jewish civil rights group that has been tracking cases since 1979, found that there were 2,717 incidents in 2021. This represents an increase of 34% over 2020. In Europe, the European Commission found…

EUROPEAN Union governments have agreed to ration natural gas this winter to protect themselves against any further supply cuts by Russia as Moscow…

Despite most energy ministers backing the scheme the EU was forced to water down proposals